Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
80Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-13.14M | $-0.29 |
| 2024 | $0.00 | $-11.44M | $-0.73 |
| 2023 | $0.00 | $-10.74M | $-1.05 |
| 2022 | $0.00 | $-13.17M | $-1.81 |
| 2021 | $0.00 | $-11.31M | $-1.59 |
Social Signal Score
Earnings
Wed, Nov 11(in 3 months)
Consensus estimate $-0.07 per share
Typical surprise -4.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-0.08 vs $-0.08miss
- Wed, May 13$-0.05 vs $-0.08beat
- Thu, Mar 26$-0.04 vs $-0.06beat
- Wed, Nov 12$-0.07 vs $-0.06miss
- Tue, Aug 12$-0.10 vs $-0.08miss
- Wed, May 14$-0.08 vs $-0.13beat
Estimates and results for MBOT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
MBOThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newszacks.com·4d ago·Negative
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates Microbot Medical Inc. (MBOT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago.
View source ↗